Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour - PubMed (original) (raw)
Case Reports
Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour
S Park et al. Nat Genet. 1993 Dec.
Abstract
Nephrogenic rests consist of foci of primitive renal cells, typically microscopic, that are found within the normal kidney tissue of children with Wilms' tumour. To study the relationship between nephrogenic rests and the associated tumours, we screened these lesions for mutations in the 11p13 Wilms' tumour suppressor gene, WT1. In two cases in which the Wilms' tumour contained a somatic WT1 mutation, the nephrogenic rest had the identical mutation. Nephrogenic rests and Wilms' tumours are therefore topographically distinct lesions that are clonally derived from an early renal stem cell. Inactivation of WT1 appears to be an early genetic event which can lead to the formation of nephrogenic rests, enhancing the probability that additional genetic hits will lead to Wilms' tumour.
Similar articles
- Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K, Fleming S. Pritchard-Jones K, et al. Oncogene. 1991 Dec;6(12):2211-20. Oncogene. 1991. PMID: 1722569 - Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M, König A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, et al. Gessler M, et al. Hum Mutat. 1994;3(3):212-22. doi: 10.1002/humu.1380030307. Hum Mutat. 1994. PMID: 8019557 - Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK, Brown KW, Berry PJ. Charles AK, et al. Am J Pathol. 1998 Sep;153(3):991-1000. doi: 10.1016/S0002-9440(10)65641-6. Am J Pathol. 1998. PMID: 9736048 Free PMC article. - Role of the WT1 gene in Wilms' tumour.
Haber DA, Housman DE. Haber DA, et al. Cancer Surv. 1992;12:105-17. Cancer Surv. 1992. PMID: 1322241 Review. - WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
Haber DA, Buckler AJ. Haber DA, et al. New Biol. 1992 Feb;4(2):97-106. New Biol. 1992. PMID: 1313285 Review.
Cited by
- Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.
Burr R, Leshchiner I, Costantino CL, Blohmer M, Sundaresan T, Cha J, Seeger K, Guay S, Danysh BP, Gore I, Jacobs RA, Slowik K, Utro F, Rhrissorrakrai K, Levovitz C, Barth JL, Dubash T, Chirn B, Parida L, Sequist LV, Lennerz JK, Mino-Kenudson M, Maheswaran S, Naxerova K, Getz G, Haber DA. Burr R, et al. Nat Cancer. 2024 Nov;5(11):1681-1696. doi: 10.1038/s43018-024-00840-y. Epub 2024 Oct 15. Nat Cancer. 2024. PMID: 39406916 Free PMC article. - Characterization of Alternative Splicing in High-Risk Wilms' Tumors.
Trink Y, Urbach A, Dekel B, Hohenstein P, Goldberger J, Kalisky T. Trink Y, et al. Int J Mol Sci. 2024 Apr 20;25(8):4520. doi: 10.3390/ijms25084520. Int J Mol Sci. 2024. PMID: 38674106 Free PMC article. - Somatic, Genetic and Epigenetic Changes in Nephrogenic Rests and Their Role in the Transformation to Wilms Tumors, a Systematic Review.
Bánki T, Drost J, van den Heuvel-Eibrink MM, Mavinkurve-Groothuis AMC, de Krijger RR. Bánki T, et al. Cancers (Basel). 2023 Feb 21;15(5):1363. doi: 10.3390/cancers15051363. Cancers (Basel). 2023. PMID: 36900155 Free PMC article. Review. - MicroRNAs in kidney development and disease.
Cerqueira DM, Tayeb M, Ho J. Cerqueira DM, et al. JCI Insight. 2022 May 9;7(9):e158277. doi: 10.1172/jci.insight.158277. JCI Insight. 2022. PMID: 35531954 Free PMC article. Review. - The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor.
Legge D, Li L, Moriarty W, Lee D, Szemes M, Zahed A, Panousopoulos L, Chung WY, Aghabi Y, Barratt J, Williams R, Pritchard-Jones K, Malik KTA, Oltean S, Brown KW. Legge D, et al. Mol Oncol. 2022 Feb;16(3):630-647. doi: 10.1002/1878-0261.13101. Epub 2021 Sep 28. Mol Oncol. 2022. PMID: 34520622 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical